首页 正文

Dupilumab in chronic rhinosinusitis without nasal polyps: randomized phase 2 trial (ORION)

{{output}}
Background: Chronic rhinosinusitis (CRS) is often driven by type 2 inflammation and is characterized by nasal obstruction/ discharge, facial pain/pressure, and/or reduced smell, either with or without nasal polyps (CRSwNP or CRSs... ...